CN214180706U

CN214180706U - Hybrid braided stent

Info

Publication number: CN214180706U
Application number: CN202022582051.3U
Authority: CN
Inventors: 焦力群; 李爽; 夏洁; 汪泽辉
Original assignee: Suzhou Zhongtian Medical Device Technology Co ltd
Current assignee: Suzhou Zhongtian Medical Device Technology Co ltd
Priority date: 2020-11-10
Filing date: 2020-11-10
Publication date: 2021-09-14
Anticipated expiration: 2030-11-10

Abstract

The utility model belongs to the technical field of medical instrument, concretely relates to mix and weave support. The hybrid braided stent comprises a stent body which is of a single-layer structure. The stent body is a tubular structure formed by weaving at least two filaments in a staggered mode, and the end areas of the at least two filaments are not completely the same. The utility model discloses a support body that support was woven in mixture is woven by two piece at least silk bodies are crisscross to be woven and is formed, and the end area of two piece at least silk bodies is different. The end area of the filament body is large, so that the stent body has good supporting force to be tightly attached to a blood vessel, and good positioning is realized. The less silk body of end area makes the mesh of support body less, and the support body is installed to the blood vessel after, and the plaque atress is more even, and is difficult broken, even the plaque is broken, the support body also can effectively block the fragment flow direction of plaque to vascular low reaches. To sum up, for prior art, the utility model discloses a safety in utilization of support body is better.

Description

Hybrid braided stent

Technical Field

The utility model belongs to the technical field of medical instrument, concretely relates to mix and weave support.

Background

Cerebrovascular disease is today a major disease threatening human health, second only to cardiovascular disease and the third leading cause of death of tumors, where 25% of ischemic strokes are associated with carotid stenosis or occlusion.

The treatment of carotid stenosis is mainly divided into drug treatment, carotid endarterectomy and carotid stenting. Among them, carotid artery stent implantation has the advantages of simplicity, small wound and few complications, and is one of the effective methods for treating carotid artery stenosis at present. The carotid artery stent is generally arranged in a common carotid artery and an internal carotid artery, and after the carotid artery stent is expanded, a blood vessel which is narrowed due to lesion is expanded, so that the normal blood supply of the blood vessel is restored.

The common carotid stents at present mainly comprise a cutting stent and a braided stent.

The cutting stent is generally a cylindrical structure formed by cutting a metal pipe by laser, and is mainly divided into an open-loop structure and a closed-loop structure. The support mesh of open loop configuration is bigger, can not effectual cover plaque, and when the support release was in carotid artery stenosis position, the cradling piece produced the cutting action to the plaque easily, caused the plaque breakage to drop, and the garrulous plaque that drops can get into the brain along with the blood flow and block up the cerebral vessels, causes apoplexy or even death. The mesh size of the stent in a closed loop structure is small, so that plaque can be effectively covered, but the stent has too large supporting force and is difficult to pass through tortuous lesions.

Braided stents are mesh stents that are braided from metal wires, typically nitinol wires. For example, a double braided stent structure has been disclosed (US20160361180a1) which is divided into an outer braided stent and an inner metal mesh, the outer braided stent is braided with thicker wires, and the outer braided stent provides the main radial support force. However, the outer layer woven stent is also relatively large in mesh, difficult to cover the plaque, and does not prevent the plaque from breaking and migrating. The meshes of the inner layer metal net are small, so that the plaque is effectively prevented from flowing to the downstream of the blood vessel. The double-layer braided stent structure solves the problem that fragments enter the downstream of a blood vessel after plaque is broken. However, the outer layer woven stent and the inner layer metal mesh of the double layer woven stent have different expansion and contraction rates, and when the double layer woven stent is released to a blood vessel at a predetermined position, it is difficult to accurately control the position accuracy of the outer layer woven stent and the inner layer metal mesh. The condition that the inner-layer metal mesh cannot be tightly attached to the outer-layer woven stent is easy to occur, so that the inner-layer metal mesh cannot effectively prevent fragments from flowing to the downstream of the blood vessel.

In conclusion, the safety of the existing carotid artery stent is poor.

SUMMERY OF THE UTILITY MODEL

An object of the utility model is to provide a mix and weave support to solve the relatively poor problem of security of current carotid artery support.

To achieve the purpose, the utility model adopts the following technical proposal:

a hybrid braided stent comprises a stent body, wherein the stent body is of a single-layer structure; the stent body is of a tubular structure formed by weaving at least two filaments in a staggered mode, and the end areas of the at least two filaments are not identical.

Preferably, in the hybrid braided stent described above, the stent body has a cylindrical shape or a tapered cylindrical shape, and the material of at least two filaments is not completely the same.

Preferably, in the hybrid braided stent described above, the stent body is braided from two or more different end areas of the filaments.

Preferably, in the hybrid braided stent described above, at least one of the filaments has developability.

Preferably, in the hybrid braided stent described above, the ends of at least two of the filaments at the ends of the stent body are connected together to close the ends of the filaments.

Preferably, in the hybrid braided stent described above, the ends of every two filaments at the ends of the stent body are connected together by a sleeve, or the ends of every two filaments at the ends of the stent body are welded together to connect the ends of the two filaments into a closed curve.

Preferably, in the hybrid braided stent described above, the stent body has at least two segments, and the braiding angles of the segments are not all the same.

Preferably, in the hybrid braided stent described above, the hybrid braided stent further includes a flaring frame, the flaring frame is mounted at an end of the stent body, and the diameter of the flaring frame gradually increases in a direction away from the stent body.

Preferably, in the hybrid braided stent described above, the filament surface is provided with a smooth insulating layer.

Preferably, in the hybrid braided stent, the filament body of the end part of the stent body is formed with a bent part, and the bent part encloses a socket which is used for being in plug fit with a projection of a conveying component.

The utility model discloses a mix and weave support's beneficial effect lies in: the stent body is formed by weaving at least two filaments in a staggered mode, and the end areas of the at least two filaments are different. The end area of the filament body is large, so that the stent body has good supporting force to be tightly attached to a blood vessel, and good positioning is realized. The less silk body of end area makes the mesh of support body less, and the support body is installed to the blood vessel after, and the plaque atress is more even, and is difficult broken, even the plaque is broken, the support body also can effectively block the fragment flow direction of plaque to vascular low reaches.

To sum up, for prior art, the utility model discloses a safety in utilization of support body is better.

Drawings

FIG. 1 is a schematic diagram of the carotid artery according to an embodiment of the present invention;

FIG. 2 is a partial view of a first bracket body according to an embodiment of the present invention;

FIG. 3 is a structural diagram of a main frame woven with thick filaments according to an embodiment of the present invention;

FIG. 4 is an overall structural view of a first bracket body according to an embodiment of the present invention;

FIG. 5 is a view showing the engagement of the stent body with a blood vessel according to the embodiment of the present invention;

FIG. 6 is a first connection of two filament ends according to an embodiment of the present invention;

FIG. 7 is a second connection of two filament ends according to an embodiment of the present invention;

FIG. 8 is a view of a first bend in a filament according to an embodiment of the present invention;

fig. 9 is a structural view of a second bent portion of the filament according to an embodiment of the present invention;

FIG. 10 is a view of a third bend in the filament according to an embodiment of the present invention;

FIG. 11 is a structural view of a second bracket body according to the embodiment of the present invention;

FIG. 12 is a connection view of a stent body and a flaring frame according to an embodiment of the present invention;

figure 13 is a mating view of a hybrid braided stent and delivery assembly according to an embodiment of the present invention;

figure 14 is a partial view of a hybrid braided stent in cooperation with a delivery assembly according to an embodiment of the present invention;

fig. 15 is a perspective view of an anchor according to an embodiment of the present invention;

fig. 16 is a process diagram of an embodiment of the present invention for installing a hybrid braided stent via a delivery assembly;

FIG. 17 is a view showing a third example of a structure of a stent body according to the present invention;

fig. 18 is a schematic view of a fourth stent body according to an embodiment of the present invention.

The component names and designations in the drawings are as follows:

carotid artery 10, common carotid artery 11, internal carotid artery 12, external carotid artery 13, plaque 14, stent body 20, thin filament 21, thick filament 22, intermediate filament 23, proximal end 24, distal end 25, first bend 26, second bend 27, third bend 28, sleeve 30, flared scaffold 40, reinforcing rod 41, weld 50, delivery assembly 60, handle 61, catheter 62, mandrel 63, head 64, anchor 65, protrusion 651.

Detailed Description

The present invention will be described in further detail with reference to the accompanying drawings and examples. It is to be understood that the specific embodiments described herein are merely illustrative of the invention and are not limiting of the invention. It should be further noted that, for the convenience of description, only some of the structures related to the present invention are shown in the drawings, not all of the structures.

In the description of the present invention, unless expressly stated or limited otherwise, the terms "connected," "connected," and "fixed" are to be construed broadly, e.g., as meaning permanently connected, detachably connected, or integral to one another; can be mechanically or electrically connected; either directly or indirectly through intervening media, either internally or in any other relationship. The specific meaning of the above terms in the present invention can be understood in specific cases to those skilled in the art.

In the present disclosure, unless expressly stated or limited otherwise, the first feature "on" or "under" the second feature may comprise direct contact between the first and second features, or may comprise contact between the first and second features not directly. Also, the first feature being "on," "above" and "over" the second feature includes the first feature being directly on and obliquely above the second feature, or merely indicating that the first feature is at a higher level than the second feature. A first feature being "under," "below," and "beneath" a second feature includes the first feature being directly under and obliquely below the second feature, or simply meaning that the first feature is at a lesser elevation than the second feature.

In the description of the present embodiment, the terms "upper", "lower", "right", etc. are used in an orientation or positional relationship based on that shown in the drawings only for convenience of description and simplicity of operation, and do not indicate or imply that the device or element referred to must have a particular orientation, be constructed and operated in a particular orientation, and thus, should not be construed as limiting the present invention. Furthermore, the terms "first" and "second" are used only for descriptive purposes and are not intended to have a special meaning.

Example one

Fig. 1 is a schematic structural view of a carotid artery 10 according to an embodiment of the present invention. As shown in fig. 1, the carotid artery 10 is divided into a common carotid artery 11, an internal carotid artery 12, and an external carotid artery 13, and the common carotid artery 11, the internal carotid artery 12, and the external carotid artery 13 form a Y-shaped bifurcation structure. The blood of the common carotid artery 11 flows into the internal carotid artery 12 and the external carotid artery 13, respectively, at the Y-shaped bifurcation. Wherein blood from the internal carotid artery 12 mainly flows to the brain and blood from the external carotid artery 13 mainly supplies facial organs. The common carotid artery 11 and the internal carotid artery 12 have plaques 14, and the plaques 14 cause narrowing of the blood vessel and affect the blood circulation. Therefore, a stent is required to be installed at the lesion to enlarge the blood vessel and ensure the normal blood flow.

Fig. 2 is a partial structural view of a first bracket body 20 according to an embodiment of the present invention. As shown in fig. 2, the present embodiment discloses a hybrid braided stent including a stent body 20, the stent body 20 having a single-layered structure. The stent body 20 has a tubular structure formed by interlacing at least two filaments, for example, the stent body 20 may have a tubular structure, or as shown in fig. 17, the stent body 20 may have a conical tubular structure to adapt to the shape of a blood vessel. The end areas of at least two filaments are not identical. Wherein, when the stent body 20 is a cone-shaped structure, the diameter is gradually reduced from the proximal end to the distal end. Due to the fact that the diameters of the blood vessels at different positions are different, the conical and cylindrical structure can adapt to the change of the diameters of the blood vessels. Compare with cylindric structure, this awl tubular structure implants the blood vessel after, better with the laminating degree of vascular wall to support body 20 is difficult for causing blood vessel overexpansion more, and then is difficult for damaging the blood vessel more.

The hybrid braided stent of the present embodiment is mainly applied at a stenotic blood vessel. For example, the mixed braided stent can be applied to the narrow blood vessel at the Y-shaped bifurcation, the blood can enter the external carotid artery 13 through the meshes of the stent body 20 without causing ischemia of the external carotid artery 13, and the mixed braided stent is mounted to the common carotid artery 11 and the internal carotid artery 12.

Fig. 5 is a matching view of the stent body 20 and the blood vessel according to the embodiment of the present invention. As shown in fig. 5, the stent body 20 of the hybrid braided stent of the present invention is formed by braiding at least two filaments in a staggered manner, and the end areas of the at least two filaments are different. The filament with a large end area enables the stent body 20 to have good supporting force so as to be tightly attached to the blood vessel, thereby realizing good positioning. The mesh of the stent body 20 is smaller due to the small end area of the filament body, after the stent body 20 is installed on a blood vessel, the plaque 14 is stressed more uniformly and is not easy to break, and even if the plaque 14 is broken, the stent body 20 can also effectively block the fragments of the plaque 14 from flowing to the downstream of the blood vessel.

To sum up, for prior art, the utility model discloses a support body 20's safety in utilization is better.

In addition, the expansion and contraction rates of the support body 20 of the embodiment are basically the same, and the support body can be compressed to a smaller volume, so that the support body 20 can be accurately positioned during installation.

As shown in fig. 2, the stent body 20 is preferably woven from two filaments of different end areas. The two filaments are not made of the same material. In other embodiments, the two filaments may be the same material. Specifically, the two filaments are a fine filament 21 and a thick filament 22, respectively, and the end area of the fine filament 21 is smaller than that of the thick filament 22. Fig. 3 is a structural view of the main frame woven by the thick yarn body 22 according to the embodiment of the present invention. As shown in FIG. 3, the main frame woven by the thick filaments 22 has a large mesh size, for example, 1mm to 20mm, preferably 1mm to 10 mm. The mesh referred to in this application may be circular, diamond shaped, rectangular, etc. For non-circular meshes, the size of a mesh refers to the diameter of the inscribed circle of the mesh. The main frame is mainly used for providing supporting force between the main frame and a blood vessel.

As shown in fig. 2 and 3, the fine filament body 21 and the thick filament body 22 are mixedly woven together. The total number of the filament bodies 21 and the thick filament bodies 22 is at least more than 18, the number of the thick filament bodies 22 is at least 6, and the number of the filament bodies 21 is at least 12. The fine filament bodies 21 and the coarse filament bodies 22 are uniformly distributed. The braided stent body 20 may also be shaped by heat treatment, for example, at 400 ℃ to 600 ℃ for 30s to 20 min. The braiding angle of the fine filament body 21 and the coarse filament body 22 may be 90-180 deg..

Preferably, the end face of the filament of this embodiment may be circular, in which case the diameter of the filament 21 is 0.01mm to 0.5mm, preferably 0.01mm to 0.2 mm. The diameter of the thick filaments 22 is 0.05mm to 1.0mm, preferably 0.1mm to 0.5 mm. In other embodiments, the end face of the filament may also be rectangular in shape, i.e. the filament is a flat structure.

The presence of the filament bodies 21 makes the meshes of the entire stent body 20 small, and can block the flow of the fragments of the plaque 14 to the downstream of the blood vessel. For example, the mesh size of the stent body 20 may be 0.05mm to 2mm, preferably 0.1mm to 1 mm.

The thin wire body 21 and the thick wire body 22 are both made of medical metal wires, and the medical metal materials include medical stainless steel, nickel-titanium memory alloy, cobalt-based alloy, titanium alloy, magnesium alloy and the like, and preferably nickel-titanium memory alloy. After being released in a blood vessel, the stent body 20 can be expanded to fit the blood vessel, dilate the blood vessel, and be positioned at the installed position. The stent body 20 has good flexibility and can adapt to blood vessels with different diameters and shapes.

Fig. 4 is an overall view of a first stent body 20 according to an embodiment of the present invention, as shown in fig. 4, preferably, the ends of at least two filaments at one end or both ends of the stent body 20 are connected together to close the ends of the filaments. The ends of two filaments of the same kind may be connected together, or the ends of two filaments of different kinds may be connected together. The two ends of the stent body 20 are a proximal end 24 and a distal end 25, respectively, and the distal end 25 can be considered as: the end of the vessel is accessed first during installation. The ends of the filaments at the proximal end 24 and the distal end 25 are closed, making the proximal end 24 and the distal end 25 smoother and less prone to damage to the blood vessel. In addition, it can improve the supporting force of the stent body 20 and the storage capacity at the time of contraction.

Fig. 6 is a first connection mode diagram of two filament ends according to the embodiment of the present invention. Fig. 7 is a second connection mode diagram of two filament ends according to the embodiment of the present invention. Preferably, the ends of each two filaments of the proximal and distal ends 24, 25 are joined together by a sleeve 30, as shown in fig. 6, or the ends of each two filaments of the proximal and distal ends 24, 25 are laser welded together, as shown in fig. 7, to join the ends of the two filaments into a closed curve. In other embodiments, the ends of each two filaments of the proximal and distal ends 24, 25 may also be joined together by glue.

As shown in FIG. 6, the inner diameter of the sleeve 30 is 0.01mm-0.1mm larger than the diameter of the two filaments, the wall thickness of the sleeve 30 is 0.01mm-0.2mm, and the length is 0.5mm-5 mm. The sleeve 30 may be formed from nitinol, medical stainless steel, cobalt-based alloys, titanium alloys, or magnesium alloys, among others. Preferably, the sleeve 30 is made of developing material such as platinum-iridium alloy, gold, tantalum, platinum-tungsten alloy, etc., so that the sleeve 30 has developing property and can help to position the stent body 20. The connection process is as follows: the sleeve 30 is sleeved at the ends of the two filaments, and then the sleeve 30 is connected with the ends of the two filaments by glue, laser welding and the like, so that the sharp filament ends of the filaments are eliminated.

As shown in fig. 7, the welding process is: the ends of the two filaments are juxtaposed and then laser-drilled to form one or more welds 50 at the ends of the two filaments to join the ends of the two filaments together and thereby eliminate the sharp filament ends of the filaments.

In other embodiments, more than 3 filament ends may be joined together simultaneously to eliminate sharp ends of the filaments. In summary, after weaving, it is necessary to ensure that the stent body 20 does not form a sharp portion to protect the blood vessel. The supporting force between the stent body 20 and the blood vessel is also required to be sufficient without damaging the blood vessel.

Fig. 12 is a connection diagram of the bracket body 20 and the flaring frame 40 according to the embodiment of the present invention. As shown in fig. 12, it is preferable that the hybrid braided stent further includes a flaring frame 40, the flaring frame 40 is installed at an end portion of the stent body 20, and the diameter of the flaring frame 40 is gradually increased in a direction away from the stent body 20. The diameter of the flaring frame 40 is larger than that of the stent body 20, and after the hybrid braided stent is released in a blood vessel, the supporting force between the flaring frame 40 and the blood vessel is larger, so that the overall positioning effect of the hybrid braided stent is improved. The flaring frame 40 also includes a reinforcing rod 41, the reinforcing rod 41 enclosing a triangular configuration with the proximal end 24 or the distal end 25. The reinforcing rod 41 can improve the supporting force between the flaring frame 40 and the blood vessel, and also can store energy for the flaring frame 40 after contraction.

Preferably, at least one of the filaments has developability, so that the developability of the hybrid braided stent can be further improved, and the mounting accuracy and the mounting convenience of the hybrid braided stent can be improved. The developing filament may be platinum-iridium alloy wire, gold wire, tantalum wire, platinum-tungsten alloy wire, etc.

Preferably, the filament surfaces are provided with a smooth insulating layer to reduce friction between adjacent filaments during weaving. The smooth insulating layer can also increase the smoothness of the expansion and contraction of the stent body 20. In addition, the smooth insulating layer makes the surface smoothness of the filament good, can reduce the friction between the stent body 20 and the catheter 62, reduces the delivery resistance of the stent body 20, is beneficial to pushing and releasing the stent body 20, and can prevent the formation of thrombus. The smooth insulating layer may be a Parylene or Parylene derivative coating.

Because the filament bodies are made of different materials, potential difference can be generated between the filament bodies made of different materials, so that electrochemical corrosion is generated, metal ions are released, the supporting force of the bracket body 20 is reduced, and even the filament bodies are broken. The smooth insulating layer is arranged in the embodiment, so that metal ions on the filament body can be prevented from entering blood, electrochemical corrosion can be prevented, and the filament body can be protected.

Fig. 11 is a structural view of a second bracket body 20 according to the embodiment of the present invention. As shown in fig. 11, the stent body 20 is preferably woven from three filaments of different end areas. The three filaments are not made of the same material. In other embodiments, the three filaments may be made of the same material. The filaments of the three different end areas are respectively a fine filament 21, a thick filament 22 and an intermediate filament 23. The end area of the intermediate filaments 23 is larger than the fine filaments 21 and smaller than the coarse filaments 22. The intermediate filaments 23 serve as a transition adjustment so that the stent body 20 has a proper supporting force and mesh size. The supporting force and the mesh size of the stent body 20 can be adjusted by changing the end area and the material of the intermediate filament 23. The diameter of the intermediate filament 23 may be 0.02mm to 0.8mm, preferably 0.05mm to 0.3 mm.

Fig. 8 is a structural view of the first bent portion 26 of the filament according to the embodiment of the present invention. Fig. 9 is a structural view of a second bent portion 27 of the filament according to the embodiment of the present invention. Fig. 10 is a structural view of a third bent portion 28 of the filament according to the embodiment of the present invention. As shown in fig. 8-10, the first bent portion 26 is a spring-like structure, and the second bent portion 27 is an omega-shaped structure, which is partially open but can store energy. The third bent portion 28 is a closed loop structure. The first bent portion 26, the second bent portion 27, and the third bent portion 28 are formed on the end of the stent body 20, and the first bent portion 26, the second bent portion 27, and the third bent portion 28 have insertion openings for inserting and matching with the protrusions 651 of the conveying assembly 60. For the second bent part 27 with an opening, when the bracket body 20 is located in the conduit 62 of the conveying assembly 60, the second bent part 27 is in a closed state to be reliably inserted and matched with the protrusion 651, and is not easily separated from the protrusion 651.

The first bent portion 26, the second bent portion 27 and the third bent portion 28 are used for preventing the stent body 20 from being plastically deformed when entering the conduit 62 of the delivery assembly 60. The first bent portion 26, the second bent portion 27 and the third bent portion 28 have an energy storage function, and after the stent body 20 extends out of the catheter 62, the stent body 20 has a large opening force. The opening force is based on the premise that the blood vessel is not damaged.

Figure 13 is a diagram of a hybrid braided stent and delivery assembly 60 according to an embodiment of the present invention. Fig. 14 is a partial view of a hybrid braided stent in cooperation with a delivery assembly 60 according to an embodiment of the present invention. Fig. 15 is a perspective view of an anchor 65 according to an embodiment of the present invention. Fig. 16 is a process diagram of the installation of a hybrid braided stent by a delivery assembly 60 according to an embodiment of the present invention.

As shown in fig. 13-16, the delivery assembly 60 is used to deliver and retrieve a hybrid braided stent to a predetermined vascular site. Delivery assembly 60 includes a handle 61, a catheter 62, a mandrel 63, a head 64, and an anchor 65. The handle 61 and the head body 64 are mounted to the front end and the rear end of the spindle 63, respectively. A mandrel 63 is movably located within the catheter 62. The anchor body 65 is installed at the middle rear part of the mandrel 63, and the protrusion 651 on the anchor body 65 is used for being in inserting fit with the first bent part 26, the second bent part 27 or the third bent part 28 of the proximal end 24 of the stent body 20, so that the stent body 20 is conveniently pushed out of the catheter 62, and the hybrid woven stent can be timely recovered into the catheter 62 when the installation position is found to be inaccurate.

The stent body 20 and the flaring frame 40 can be fitted over the mandrel 63 and compressed into the catheter 62. The handle 61 is pushed forward, releasing the hybrid braided stent. During release, the flared shelf 40 at the distal end 25 will anchor the vessel first, preventing the hybrid braided stent from moving during release. The handle 61 is pulled backward to recover the hybrid braided stent.

Example two

As shown in fig. 18, the stent body 20 of the present embodiment is substantially the same as the stent body 20 of the first embodiment. For example, the stent body 20 of the present embodiment is also a tubular structure in which at least two filaments are interlaced, and the end areas of at least two filaments are not completely the same as in the present embodiment. The materials of at least two filaments are not completely the same. The stent body 20 is woven from filaments of two or three different end areas.

The stent body 20 of the present embodiment is different from the stent body 20 of the first embodiment in that: the stent body 20 of this embodiment has at least two segments, each having a braid angle that is not exactly the same to better accommodate vessel variations.

For example, the stent body 20 of the present embodiment has two stages, the left stage has a larger braiding angle a and the right stage has a smaller braiding angle a in fig. 18. The section with the larger weaving angle a is arranged at the position with the larger diameter of the blood vessel, and the section with the smaller weaving angle a is arranged at the position with the smaller diameter of the blood vessel. Each section can provide enough radial supporting force, and the section with the smaller weaving angle a has smaller chronic outward force relative to the section with the larger weaving angle a, so that the damage to the small-diameter blood vessel can be reduced while expanding the blood vessel.

Under the condition that the diameters of all the sections are the same, different sections of the stent body 20 have different radial supporting force and chronic outward force, and the applicability is better.

It is obvious that the above embodiments of the present invention are only examples for clearly illustrating the present invention, and are not intended to limit the embodiments of the present invention. Numerous obvious variations, rearrangements and substitutions will now occur to those skilled in the art without departing from the scope of the invention. And are neither required nor exhaustive of all embodiments. Any modification, equivalent replacement, and improvement made within the spirit and principle of the present invention should be included in the protection scope of the claims of the present invention.

Claims

1. A hybrid braided stent comprising a stent body (20), said stent body (20) being of a single-layer structure; the stent body (20) is of a cylindrical structure formed by interweaving at least two filaments, and the end areas of the at least two filaments are not completely the same.

2. The hybrid braided stent of claim 1, wherein the stent body (20) is cylindrical or tapered, and the material of at least two filaments is not completely the same.

3. The hybrid braided stent of claim 1 wherein said stent body (20) is braided from two or more different end areas of said filaments.

4. The hybrid braided stent of claim 1 wherein at least one of said filaments is developable.

5. The hybrid braided stent of claim 1 wherein the ends of at least two of the filaments at the ends of the stent body (20) are connected together to close the ends of the filaments.

6. The hybrid braided stent of claim 5, wherein the ends of each two filaments at the ends of the stent body (20) are joined together by a sleeve (30) or the ends of each two filaments at the ends of the stent body (20) are welded together to join the ends of the two filaments into a closed curve.

7. The hybrid braided stent of claim 1 wherein the stent body (20) has at least two segments, the braid angle of each segment not being identical.

8. The hybrid braided stent of claim 1 further comprising a flaring frame (40), said flaring frame (40) being mounted at an end of said stent body (20), said flaring frame (40) having a progressively larger diameter in a direction away from said stent body (20).

9. The hybrid braided stent of claim 1 wherein the filament surface is provided with a smooth insulating layer.

10. The hybrid braided stent of claim 1, wherein the filaments at the ends of the stent body (20) are formed with bends that enclose sockets for mating with projections (651) of a delivery assembly (60).